IL162349A0 - Preparation of trans-fused 3,3a,8,12b-tetrahydro-2h-dibenzo Ä3,4:6,7Ücyclohepta Ä1,2-bÜfuran derivatives - Google Patents
Preparation of trans-fused 3,3a,8,12b-tetrahydro-2h-dibenzo Ä3,4:6,7Ücyclohepta Ä1,2-bÜfuran derivativesInfo
- Publication number
- IL162349A0 IL162349A0 IL16234902A IL16234902A IL162349A0 IL 162349 A0 IL162349 A0 IL 162349A0 IL 16234902 A IL16234902 A IL 16234902A IL 16234902 A IL16234902 A IL 16234902A IL 162349 A0 IL162349 A0 IL 162349A0
- Authority
- IL
- Israel
- Prior art keywords
- fused
- trans
- preparation
- büfuran
- dibenzo
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Addiction (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01204961 | 2001-12-07 | ||
PCT/EP2002/013560 WO2003048146A1 (en) | 2001-12-07 | 2002-12-02 | PREPARATION OF TRANS-FUSED 3,3a,8,12b-TETRAHYDRO-2H-DIBENZO[3,4:6,7]CYCLOHEPTA[1,2-b]FURAN DERIVATIVES |
Publications (1)
Publication Number | Publication Date |
---|---|
IL162349A0 true IL162349A0 (en) | 2005-11-20 |
Family
ID=8181460
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL16234902A IL162349A0 (en) | 2001-12-07 | 2002-12-02 | Preparation of trans-fused 3,3a,8,12b-tetrahydro-2h-dibenzo Ä3,4:6,7Ücyclohepta Ä1,2-bÜfuran derivatives |
Country Status (21)
Country | Link |
---|---|
US (2) | US6998494B2 (xx) |
EP (1) | EP1456193B1 (xx) |
JP (1) | JP4516752B2 (xx) |
KR (1) | KR20050044329A (xx) |
CN (1) | CN1293066C (xx) |
AT (1) | ATE294168T1 (xx) |
AU (1) | AU2002342926B2 (xx) |
BR (1) | BR0214068A (xx) |
CA (1) | CA2468038C (xx) |
DE (1) | DE60203937T2 (xx) |
ES (1) | ES2242076T3 (xx) |
HK (1) | HK1076461A1 (xx) |
HR (1) | HRP20040490A2 (xx) |
HU (1) | HUP0402152A3 (xx) |
IL (1) | IL162349A0 (xx) |
MX (1) | MXPA04005400A (xx) |
NO (1) | NO20042884L (xx) |
NZ (1) | NZ532806A (xx) |
PL (1) | PL369585A1 (xx) |
WO (1) | WO2003048146A1 (xx) |
ZA (1) | ZA200404394B (xx) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6998494B2 (en) * | 2001-12-07 | 2006-02-14 | Janssen Pharmaceutica N.V. | Preparation of trans-fused 3,3a,8,12b-tetrahydro-2h-dibenzo[3,4:6,7]cyclohepta[1,2-b]furan derivatives |
WO2005013969A1 (en) * | 2003-07-15 | 2005-02-17 | Janssen Pharmaceutica N.V. | Antipsychotic agent with socializing properties |
US20070197525A1 (en) * | 2004-06-14 | 2007-08-23 | Cid-Nunez Jose M | Novel tetracyclic tetrahydrofuran derivatives |
US7470809B2 (en) * | 2004-08-31 | 2008-12-30 | Janssen Pharmaceutica N.V. | Process for the production of [2-(4-fluoro-benzyl)-phenyl]-acetic acid |
CA2588760C (en) | 2004-12-07 | 2014-05-13 | Janssen Pharmaceutica N.V. | Substituted tetracyclic tetrahydropyran, pyrrolidine and tetrahydrothiophene derivatives |
EA013595B1 (ru) | 2005-01-27 | 2010-06-30 | Янссен Фармацевтика Н.В. | Гетероциклические, тетрациклические производные гидрофурана в качестве ингибиторов 5htв терапии расстройств цнс |
ES2342110T3 (es) | 2005-06-17 | 2010-07-01 | Janssen Pharmaceutica Nv | Nuevos derivados tetraciclicos de tetrahidrofurano que contienen una cadena lateral de amina ciclica. |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT892793E (pt) * | 1996-04-12 | 2003-08-29 | Janssen Pharmaceutica Nv | Derivados 2-cianoiminoimidazolo inibidores da pde iv |
UA52778C2 (uk) * | 1997-10-10 | 2003-01-15 | Янссен Фармацевтика Н.В. | Галогенозаміщені тетрациклічні похідні тетрагідрофурану, спосіб їх отримання та композиція на їх основі |
UA79248C2 (en) * | 2001-11-09 | 2007-06-11 | Janssen Pharmaceutica Nv | Mandelate salts of substituted tetracyclic tetrahydrofuran derivatives |
US6998494B2 (en) * | 2001-12-07 | 2006-02-14 | Janssen Pharmaceutica N.V. | Preparation of trans-fused 3,3a,8,12b-tetrahydro-2h-dibenzo[3,4:6,7]cyclohepta[1,2-b]furan derivatives |
CN1697833A (zh) * | 2001-12-07 | 2005-11-16 | 詹森药业有限公司 | 顺式-稠合的3,3a,8,12b-四氢-2H-二苯并[3,4:6,7]环庚并[1,2-b]呋喃衍生物的制备方法 |
-
2002
- 2002-12-02 US US10/496,279 patent/US6998494B2/en not_active Expired - Fee Related
- 2002-12-02 EP EP02779576A patent/EP1456193B1/en not_active Expired - Lifetime
- 2002-12-02 JP JP2003549337A patent/JP4516752B2/ja not_active Expired - Fee Related
- 2002-12-02 BR BR0214068-3A patent/BR0214068A/pt not_active Withdrawn
- 2002-12-02 HU HU0402152A patent/HUP0402152A3/hu unknown
- 2002-12-02 MX MXPA04005400A patent/MXPA04005400A/es active IP Right Grant
- 2002-12-02 DE DE60203937T patent/DE60203937T2/de not_active Expired - Lifetime
- 2002-12-02 CN CNB028244885A patent/CN1293066C/zh not_active Expired - Fee Related
- 2002-12-02 AT AT02779576T patent/ATE294168T1/de not_active IP Right Cessation
- 2002-12-02 ES ES02779576T patent/ES2242076T3/es not_active Expired - Lifetime
- 2002-12-02 IL IL16234902A patent/IL162349A0/xx not_active IP Right Cessation
- 2002-12-02 CA CA2468038A patent/CA2468038C/en not_active Expired - Fee Related
- 2002-12-02 AU AU2002342926A patent/AU2002342926B2/en not_active Ceased
- 2002-12-02 PL PL02369585A patent/PL369585A1/xx not_active Application Discontinuation
- 2002-12-02 NZ NZ532806A patent/NZ532806A/en unknown
- 2002-12-02 WO PCT/EP2002/013560 patent/WO2003048146A1/en active IP Right Grant
- 2002-12-02 KR KR1020047005553A patent/KR20050044329A/ko not_active Application Discontinuation
-
2004
- 2004-05-31 HR HR20040490A patent/HRP20040490A2/hr not_active Application Discontinuation
- 2004-06-03 ZA ZA200404394A patent/ZA200404394B/en unknown
- 2004-07-07 NO NO20042884A patent/NO20042884L/no not_active Application Discontinuation
-
2005
- 2005-05-31 US US11/141,612 patent/US20050228043A1/en not_active Abandoned
- 2005-09-23 HK HK05108415A patent/HK1076461A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
US6998494B2 (en) | 2006-02-14 |
HK1076461A1 (en) | 2006-01-20 |
KR20050044329A (ko) | 2005-05-12 |
WO2003048146A1 (en) | 2003-06-12 |
BR0214068A (pt) | 2004-10-13 |
HRP20040490A2 (en) | 2004-10-31 |
MXPA04005400A (es) | 2004-10-11 |
NO20042884L (no) | 2004-07-07 |
JP4516752B2 (ja) | 2010-08-04 |
US20050014820A1 (en) | 2005-01-20 |
ATE294168T1 (de) | 2005-05-15 |
HUP0402152A2 (hu) | 2005-02-28 |
DE60203937D1 (de) | 2005-06-02 |
PL369585A1 (en) | 2005-05-02 |
US20050228043A1 (en) | 2005-10-13 |
CN1293066C (zh) | 2007-01-03 |
CA2468038C (en) | 2011-04-26 |
JP2005511691A (ja) | 2005-04-28 |
DE60203937T2 (de) | 2006-05-11 |
CA2468038A1 (en) | 2003-06-12 |
CN1602306A (zh) | 2005-03-30 |
EP1456193A1 (en) | 2004-09-15 |
EP1456193B1 (en) | 2005-04-27 |
NZ532806A (en) | 2006-01-27 |
ZA200404394B (en) | 2005-09-05 |
ES2242076T3 (es) | 2005-11-01 |
HUP0402152A3 (en) | 2007-03-28 |
AU2002342926B2 (en) | 2009-02-26 |
AU2002342926A1 (en) | 2003-06-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1076461A1 (en) | Preparation of trans-fused 3,3a,8,12b-tetrahydro-2h-dibenzoÄ3,4;6,7ÜcycloheptaÄ1,2-bÜfuran derivatives | |
NZ522568A (en) | Substituted bicyclic derivatives for the treatment of abnormal cell growth | |
AU2001232287A1 (en) | Novel pyrazine derivatives or salts thereof, pharmaceutical compositions containing the derivatives or the salts and intermediates for the preparation of both | |
AUPR213700A0 (en) | Antiviral agents | |
HK1071129A1 (en) | Novel compounds | |
YU2101A (sh) | Antiparazitski derivati artemisinina (endoperoksidi) | |
CA2445306A1 (en) | Process for preparing 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives | |
HUP9701048A2 (hu) | Új eljárás sildenafil előállítására és a felhasznált új köztitermékek | |
HK1070063A1 (en) | Stable polymorph of flibanserin, technical processfor its preparation and the use thereof for prepa ring medicaments | |
MXPA04000755A (es) | Nuevos compuestos. | |
MXPA03012013A (es) | Derivados de 1-oxa-2,8-diaza-spiro[4,5]dec-2-eno sustituidos como medicamento para el tratamiento de dolor. | |
YU94103A (sh) | Novi derivati sulfonske kiseline | |
TNSN07485A1 (fr) | Derives de n-(arylalkyl)-1h-pyrrolopyridine -2- carboxamides, leur preparation et leur application en therapeutique | |
HU895657D0 (en) | Process for the preparation of mevalonolactones containing thienopyridine ring and pharmaceutical compositions containing such acitve ingredients | |
MXPA04005399A (es) | Preparacion de derivados cis-fusionados de 3, 3a, 8, 12b-tetrahidro-2h-dibenzo [3,4:6,7]ciclohepta[1,2-b]furano. | |
PL367774A1 (en) | Synthesis and intermediates | |
WO2001056992A3 (en) | Dibenzo (b,f) azepine intermediates | |
AU6220300A (en) | Benzofurylpiperazine serotonin agonists | |
HK1066225A1 (en) | Processes for preparing pesticidal intermediates | |
MXPA05008400A (es) | Derivados de oxazolidinona n-sustituidos por un anillo triciclico, para su uso como agentes antibacterianos. | |
WO2004065360A3 (en) | Piperazine derivatives and their use as synthesis intermediates | |
BG108151A (en) | Caloporoside derivatives, methods for the production thereof and their use | |
MXPA02003639A (es) | Proceso nuevo para la sintesis de (3as)-5, 5-dioxo-2, 3, 3a-4- tetrahidro-1h-pirrolo[2, 1c][1, 2, 4] benzotiadiazina. | |
EE200300058A (et) | Imidaso[1,2-c] [2,3] bensodiasepiinide valmistamismeetod ja vaheühendid nende valmistamisel | |
EP1241167A4 (en) | DERIVATIVES OF 3-ETHYL-, 3-PROPYL-, OR 3-BUTYL-CHROMANE AND -THIOCHROMANE |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
MM9K | Patent not in force due to non-payment of renewal fees |